20 Feb 2020 --- Industry spotlights human milk oligosaccharides (HMOs) on labels due to their beneficial health properties, but an impending EU Regulation is to set stricter marketing requirements. The move seeks to assure that advertising does not overexaggerate nutrient claims or mislead consumers. The news comes as a new study conducted at the University of California – San Diego, US, showed that HMOs found in breast milk may influence a child’s growth from infancy through early childhood, while maternal obesity may affect HMO composition in breast milk. The study emphasizes the central role and abundant opportunities HMOs hold not only for the infant formula sector but for nutrition in general.
